New and Exploratory Therapeutic Agents for Asthma

<p>Discusses three major classes of asthma therapies-bronchodilators antiinflammatories and antiallergics-as well as potential new therapeutic approaches!<br>This comprehensive volume addresses the latest treatment strategies for asthma keying in on the genetics and molecular biology of asthma and pointing the way toward new commercially viable therapies.<br>Presents the most up-to-date information available on the genetics epidemiology pathology pharmacology and pulmonology of asthma.<br>Written by more than 20 leading international experts New and Exploratory Therapeutic Agents for Asthma</p><li>explores asthma both as incidence of dysfunctional airway smooth muscle and as a disorder of the immune system <br> </li><li>examines the role of monoclonal antibodies in allergy and asthma <br> </li><li>describes functions and pharmacokinetic profiles of bronchodilator 2 agonists anticholinergics and inhaled glucocorticosteroids <br> </li><li>investigates the controversy of different types of asthma <br> </li><li>illustrates the connections between clinical symptoms and the immunopathology of eosinophilic inflammation <br> </li><li>assesses prospects for the development of a successful oral anti-inflammatory therapy an immunomodulator that lowers antigen-specific IgE an anticytokine compound and an agent that safely combines bronchospasmolytic and anti-inflammatory properties <br> </li><li>reviews the impact of the recent introduction of antileukotriene agents clinical findings with PAF antagonists and selective antimuscarinics <br> </li><li>evaluates the relationship between improvements in laboratory results and clinical effectiveness <br> </li><li>and more!<br>Containing over 2000 bibliographic citations and a concise introduction for each chapter New and Exploratory Therapeutic Agents for Asthma is indispensable for pulmonologists pediatricians physiologists immunologists allergists pharmaceutical industry scientists primary care physicians and medical s</li>